Rankings
▼
Calendar
MNKD Q2 2021 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$813M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$23M
+54.0% YoY
Gross Profit
$13M
57.4% margin
Operating Income
-$10M
-44.1% margin
Net Income
-$36M
-152.6% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
+33.5%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$23M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$253M
Total Liabilities
$436M
Stockholders' Equity
-$184M
Cash & Equivalents
$63M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$23M
$15M
+54.0%
Gross Profit
$13M
$9M
+41.3%
Operating Income
-$10M
-$8M
-29.8%
Net Income
-$36M
-$10M
-246.5%
Revenue Segments
License And Service
$6M
100%
← FY 2021
All Quarters
Q3 2021 →